2024-09-08 - Analysis Report
## CVS Stock Analysis

**Company Overview:** CVS Health Corporation is a healthcare company that operates retail pharmacy, pharmacy benefit management, and health care services. 

**1. Performance vs. S&P 500:**

CVS has underperformed significantly compared to the S&P 500 (VOO) with a cumulative return of -20.49% compared to the S&P 500's 81.34%. The relative divergence is currently -101.83%, indicating a significant underperformance compared to the market. 

**2. Recent Price Movements:**

* Closing Price: 57.75
* 5-Day Moving Average: 57.95
* 20-Day Moving Average: 57.66
* 60-Day Moving Average: 58.78

The stock is currently trading slightly below its 5-day and 20-day moving averages, indicating potential short-term downward pressure. However, the 60-day moving average is still higher, suggesting a longer-term upward trend.

**3. Technical Indicators:**

* RSI: 46.42
* PPO: 0.14
* Delta_Previous_Relative_Divergence: -2.21 (Short-term downtrend)
* Expected_Return: 11.7% (5-year potential return)

The RSI indicates a neutral market sentiment, while the PPO suggests some short-term selling pressure. The negative relative divergence reinforces the recent downward trend, but the positive expected return suggests potential growth in the long term.

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

The most recent earnings (2024-08-07) beat expectations, with an EPS of 1.83 against an expected EPS of 1.73. However, the EPS has been declining in recent quarters, reflecting the challenging market environment.

**5. Summary:**

CVS is facing significant headwinds, including market underperformance, short-term price weakness, and declining earnings. While the technical indicators suggest potential for long-term growth, the company needs to demonstrate a clear path to improve its performance and regain investor confidence.

**6. Overall Analysis:**

CVS currently presents a mixed picture. While the company has faced challenges recently, its long-term growth potential remains. However, investors should carefully consider the current market sentiment and recent earnings trends before making any investment decisions. Further analysis, including a deep dive into the company's future strategies and market position, is needed for a comprehensive assessment. 
